| Literature DB >> 26450781 |
Evangelos Giannitsis1, Johannes Mair2, Christina Christersson3, Agneta Siegbahn4, Kurt Huber5, Allan S Jaffe6, W Frank Peacock7, Mario Plebani8, Kristian Thygesen9, Martin Möckel10, Christian Mueller11, Bertil Lindahl12.
Abstract
D-dimer testing is important to aid in the exclusion of venous thromboembolic events (VTEs), including deep venous thrombosis and pulmonary embolism, and it may be used to evaluate suspected aortic dissection. D-dimer is produced upon activation of the coagulation system with the generation and subsequent degradation of cross-linked fibrin by plasmin. Many different assays for D-dimer testing are currently used in routine care. However, these tests are neither standardized nor harmonized. Consequently, only clinically validated assays and assay specific decision limits should be used for routine testing. For the exclusion of pulmonary embolism/deep vein thrombosis, age-adjusted cut-offs are recommend. Clinicians must be aware of the validated use of their hospital's D-dimer assay to avoid inappropriate use of this biomarker in routine care.Entities:
Keywords: D-dimer; acute cardiovascular care; pulmonary embolism; thrombosis
Mesh:
Substances:
Year: 2016 PMID: 26450781 DOI: 10.1177/2048872615610870
Source DB: PubMed Journal: Eur Heart J Acute Cardiovasc Care ISSN: 2048-8726